Krause Irit, Shamir Raanan, Davidovits Miriam, Frishman Sigal, Cleper Roxana, Gamzo Zahava, Poraz Irit, Eisenstein Bella
Nephrology Clinic and Dialysis Unit, Schneider Children's Medical Center of Israel, Petah Tiqva, Israel.
J Ren Nutr. 2002 Jan;12(1):55-9. doi: 10.1053/jren.2002.29601.
To examine the feasibility and effectiveness of intradialytic parenteral nutrition (IDPN) in children on hemodialysis.
Prospective experimental study with a single intervention group.
A pediatric hemodialysis unit.
Four malnourished children on hemodialysis (3 girls and 1 boy) 4 to 18 years of age were studied during a period of 1 year.
IDPN, which is composed of amino acids (8.5% solution), glucose (as 10% to 15% dextrose), and 20% fat emulsion, was administered at every dialysis session (3 times a week, during 4 hours each time) for 7 to 12 weeks.
Oral caloric intake (evaluated by using a 3-day diet history), dry weight (weight after dialysis), body mass index, percent ideal body weight, total lymphocyte count, and serum levels of albumin before, immediately after cessation of IDPN, and 3 months after cessation of IDPN.
Oral caloric intake increased markedly after IDPN administration, from 5 to 63 kcal/kg/d (mean, 33 kcal/kg/d) before IDPN administration to 35 to 177 kcal/kg/d (mean, 86 kcal/kg/d) at the time of cessation. Weight did not change during the treatment period but it did increase from 9.5 to 36.4 kg (mean, 25 kg) to 11 to 39 kg (mean, 26.7 kg) 3 months later. Percent ideal body weight increased from 73% to 88% (mean, 78.5%) to 79% to 90% (mean, 85.1%), and body mass index increased from 12.2 to 15 kg/m(2) (mean, 13.5 kg/m(2)) to 13.4 to 15.5 kg/m(2) (mean, 14.6 kg/m(2)). Total lymphocyte count increased from 538 to 2,041 cells/mm(3) (mean, 1,403 cells/mm(3)) to 724 to 2,884 cells/mm(3) (mean, 2,066 cells/mm(3)). Plasma levels of albumin increased in 1 patient but remained unchanged in others.
Short-term IDPN treatment may serve as a safe and effective nutritional intervention in malnourished children on hemodialysis.
探讨透析期间胃肠外营养(IDPN)用于接受血液透析儿童的可行性及有效性。
对单一干预组进行前瞻性实验研究。
一家儿科血液透析科室。
4名接受血液透析的营养不良儿童(3名女孩和1名男孩),年龄在4至18岁,研究为期1年。
IDPN由氨基酸(8.5%溶液)、葡萄糖(10%至15%葡萄糖)和20%脂肪乳剂组成,每次透析时(每周3次,每次4小时)给药,持续7至12周。
口服热量摄入(通过3天饮食记录评估)、干体重(透析后体重)、体重指数、理想体重百分比、总淋巴细胞计数,以及在开始IDPN前、停止IDPN后即刻和停止IDPN后3个月时的血清白蛋白水平。
给予IDPN后,口服热量摄入显著增加,从IDPN给药前的5至63千卡/千克/天(平均33千卡/千克/天)增至停止给药时的35至177千卡/千克/天(平均86千卡/千克/天)。治疗期间体重未改变,但3个月后从9.5至36.4千克(平均25千克)增至11至39千克(平均26.7千克)。理想体重百分比从73%至88%(平均78.5%)增至79%至90%(平均85.1%),体重指数从12.2至15千克/米²(平均13.5千克/米²)增至13.4至15.5千克/米²(平均14.6千克/米²)。总淋巴细胞计数从538至2041细胞/立方毫米(平均1403细胞/立方毫米)增至724至2884细胞/立方毫米(平均2066细胞/立方毫米)。1例患者血浆白蛋白水平升高,其他患者则无变化。
短期IDPN治疗可作为接受血液透析的营养不良儿童的一种安全有效的营养干预措施。